Reply: What Happened to Electrocardiogram as a Screening Test to Recognize Cardiovascular Complications in COVID-19 Patients?

Anuradha Lala; James Januzzi; Sean P. Pinney; Donna M. Mancini; Valentin Fuster

doi:10.1016/j.jacc.2020.10.013

Reply: What Happened to Electrocardiogram as a Screening Test to Recognize Cardiovascular Complications in COVID-19 Patients?

Anuradha Lala, James Januzzi, Sean P. Pinney, Donna M. Mancini, Valentin Fuster

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2800-2801
Number of pages	2
Journal	Journal of the American College of Cardiology
Volume	76
Issue number	23
DOIs	https://doi.org/10.1016/j.jacc.2020.10.013
State	Published - 8 Dec 2020

Access to Document

10.1016/j.jacc.2020.10.013

Cite this

@article{a624a32bde8543e09aced4d903b2c9d9,

title = "Reply: What Happened to Electrocardiogram as a Screening Test to Recognize Cardiovascular Complications in COVID-19 Patients?",

author = "Anuradha Lala and James Januzzi and Pinney, {Sean P.} and Mancini, {Donna M.} and Valentin Fuster",

note = "Funding Information: Dr. Lala has received speaker honoraria from Zoll. Dr. Januzzi is a Trustee of the American College of Cardiology; has received grant support from Novartis Pharmaceuticals and Abbott Diagnostics; has received consulting income from Abbott, Janssen, Novartis, MyoKardia, and Roche Diagnostics; and participates in clinical endpoint committees/data safety monitoring boards for Abbott, AbbVie, Amgen, CVRx, Janssen, and Takeda. Dr. Pinney has received consulting fees from Abbott, CareDx, Medtronic, and Procyrion; has participated in clinical endpoint committees for Abbott, Axon, SoniVie, and Transmedics; and has received honoraria from Boston Scientific. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Patrick O'Gara, MD, served as Guest Associate Editor for this paper. P.K. Shah, MD, served as Guest Editor-in-Chief for this paper.",

year = "2020",

month = dec,

day = "8",

doi = "10.1016/j.jacc.2020.10.013",

language = "English",

volume = "76",

pages = "2800--2801",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "23",

}

TY - JOUR

T1 - Reply

T2 - What Happened to Electrocardiogram as a Screening Test to Recognize Cardiovascular Complications in COVID-19 Patients?

AU - Lala, Anuradha

AU - Januzzi, James

AU - Pinney, Sean P.

AU - Mancini, Donna M.

AU - Fuster, Valentin

N1 - Funding Information: Dr. Lala has received speaker honoraria from Zoll. Dr. Januzzi is a Trustee of the American College of Cardiology; has received grant support from Novartis Pharmaceuticals and Abbott Diagnostics; has received consulting income from Abbott, Janssen, Novartis, MyoKardia, and Roche Diagnostics; and participates in clinical endpoint committees/data safety monitoring boards for Abbott, AbbVie, Amgen, CVRx, Janssen, and Takeda. Dr. Pinney has received consulting fees from Abbott, CareDx, Medtronic, and Procyrion; has participated in clinical endpoint committees for Abbott, Axon, SoniVie, and Transmedics; and has received honoraria from Boston Scientific. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Patrick O'Gara, MD, served as Guest Associate Editor for this paper. P.K. Shah, MD, served as Guest Editor-in-Chief for this paper.

PY - 2020/12/8

Y1 - 2020/12/8

UR - http://www.scopus.com/inward/record.url?scp=85097125040&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2020.10.013

DO - 10.1016/j.jacc.2020.10.013

M3 - Letter

C2 - 33272379

AN - SCOPUS:85097125040

SN - 0735-1097

VL - 76

SP - 2800

EP - 2801

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 23

ER -